Skip to main content
    C

    Clover Health Investments Corp (CLOV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $4.95
    -0.01 (-0.20%)

    Market Cap: $2.66B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Clover Health Investments Corp (CLOV) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Clover Health Investments (CLOV) to earn $0.14 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.99B. Of 5 analysts, 3 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.20, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 60% of the ratings.

    RatingAnalystsShare
    Strong Buy120.0%
    Buy240.0%
    Hold240.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 28.6% and revenue estimates rise 22.4%.

    Fiscal year ending Dec 31, 2026
    $0.14
    EPS consensus, revenue $2.99B
    Fiscal year ending Dec 31, 2027
    $0.18
    EPS consensus, revenue $3.66B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.14$0.14 to $0.141$2.99B$2.98B to $2.99B5
    Dec 31, 2027$0.18$0.18 to $0.181$3.66B$3.46B to $3.80B5

    Quarterly Estimates

    The EPS consensus rises from -$0.05 for the quarter ending Dec 31, 2026 to $0.08 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.05-$0.05 to -$0.057$750.14M$713.56M to $779.63M7
    Mar 31, 2027$0.08$0.08 to $0.081$928.62M$906.10M to $960.58M3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202700

    EPS Trend

    The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.14$0.14$0.14$0.14$0.140.0%
    Fiscal year ending Dec 31, 2027$0.18$0.15$0.15$0.15$0.15+20.0%
    Quarter ending Mar 31, 2027$0.08$0.08$0.08$0.08$0.080.0%

    Frequently Asked Questions About CLOV

    What is the CLOV stock forecast?

    Consensus analyst estimates put Clover Health Investments's EPS at $0.14 for the fiscal year ending Dec 31, 2026, on revenue of $2.99B. The consensus rating from 5 analysts is Buy.

    How do analysts rate CLOV stock?

    Of 5 analysts covering Clover Health Investments, 1 rates it Strong Buy, 2 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from CLOV next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.14, with estimates from $0.14 to $0.14 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.18, with estimates from $0.18 to $0.18 from 1 analyst.

    What revenue do analysts expect from Clover Health Investments next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.99B, with estimates from $2.98B to $2.99B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.66B, with estimates from $3.46B to $3.80B.

    How many analysts cover CLOV?

    5 analysts rate Clover Health Investments stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.